CARLSBAD, Calif. –(BUSINESS WIRE)–Jun. 8, 2026– Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced the appointment of Ludwig Hantson, Ph.D., an accomplished global biopharmaceutical leader, to the Ionis Board of Directors, effective immediately. “We are pleased to welcome Dr.
Ionis announces appointment of Ludwig Hantson, Ph.D. to Board of Directors
calendar_today
June 8, 2026
person
Ionis Pharmaceuticals, Inc. News Releases
domain
ionis-pharmaceuticals